Mary Ellyn Witt

1.9k total citations
24 papers, 1.5k citations indexed

About

Mary Ellyn Witt is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Ellyn Witt has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Otorhinolaryngology, 17 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Ellyn Witt's work include Head and Neck Cancer Studies (22 papers), Head and Neck Surgical Oncology (15 papers) and Oral health in cancer treatment (4 papers). Mary Ellyn Witt is often cited by papers focused on Head and Neck Cancer Studies (22 papers), Head and Neck Surgical Oncology (15 papers) and Oral health in cancer treatment (4 papers). Mary Ellyn Witt collaborates with scholars based in United States, Canada and Philippines. Mary Ellyn Witt's co-authors include Daniel J. Haraf, Everett E. Vokes, Ralph R. Weichselbaum, Kerstin Stenson, Bharat B. Mittal, Joseph K. Salama, Ezra E.W. Cohen, Marcy A. List, Harold J. Pelzer and Merrill S. Kies and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Mary Ellyn Witt

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ellyn Witt United States 17 997 710 607 552 237 24 1.5k
Fred Rosen United States 13 846 0.8× 556 0.8× 669 1.1× 570 1.0× 241 1.0× 22 1.3k
A A Forastiere United States 9 1.5k 1.5× 1.1k 1.6× 911 1.5× 605 1.1× 232 1.0× 14 2.0k
T. Vuong Canada 6 1.4k 1.5× 1.1k 1.5× 776 1.3× 532 1.0× 137 0.6× 10 1.7k
Roger K.C. Ngan China 16 969 1.0× 739 1.0× 671 1.1× 503 0.9× 237 1.0× 39 1.5k
A Rey France 9 926 0.9× 758 1.1× 707 1.2× 642 1.2× 345 1.5× 11 1.7k
Lionnel Geoffrois France 21 438 0.4× 675 1.0× 595 1.0× 844 1.5× 504 2.1× 90 1.6k
John Showel United States 13 520 0.5× 398 0.6× 397 0.7× 315 0.6× 134 0.6× 23 1.0k
L. Geoffrois France 20 420 0.4× 435 0.6× 519 0.9× 555 1.0× 358 1.5× 55 1.2k
Kinji Nishiyama Japan 22 384 0.4× 768 1.1× 521 0.9× 727 1.3× 73 0.3× 63 1.6k
R. Semrau Germany 23 408 0.4× 564 0.8× 493 0.8× 478 0.9× 110 0.5× 59 1.3k

Countries citing papers authored by Mary Ellyn Witt

Since Specialization
Citations

This map shows the geographic impact of Mary Ellyn Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellyn Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellyn Witt more than expected).

Fields of papers citing papers by Mary Ellyn Witt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ellyn Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellyn Witt. The network helps show where Mary Ellyn Witt may publish in the future.

Co-authorship network of co-authors of Mary Ellyn Witt

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ellyn Witt. A scholar is included among the top collaborators of Mary Ellyn Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ellyn Witt. Mary Ellyn Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seiwert, Tanguy Y., J.M. Melotek, Elizabeth A. Blair, et al.. (2016). Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(1). 21–29. 27 indexed citations
2.
Karrison, Theodore, Mary Ellyn Witt, Charles Muller, et al.. (2014). Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal SCC over two decades.. Journal of Clinical Oncology. 32(15_suppl). 6048–6048. 1 indexed citations
3.
Maggiore, Ronald J., Emily Curran, Mary Ellyn Witt, et al.. (2013). Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy. Journal of Geriatric Oncology. 4(4). 327–333. 29 indexed citations
4.
Rudra, Sonali, Michael T. Spiotto, Mary Ellyn Witt, et al.. (2013). Lymph node density—Prognostic value in head and neck cancer. Head & Neck. 36(2). 266–272. 24 indexed citations
5.
Mouw, Kent W., Kerstin Stenson, Mary Ellyn Witt, et al.. (2012). Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy. Oral Oncology. 48(10). 1025–1030. 11 indexed citations
6.
Choe, Kevin S., Daniel J. Haraf, Ezra E.W. Cohen, et al.. (2011). Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Cancer. 117(20). 4671–4678. 54 indexed citations
7.
Cohen, Ezra E.W., Daniel J. Haraf, Rangesh Kunnavakkam, et al.. (2010). Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 28(20). 3336–3343. 64 indexed citations
8.
Choe, Kevin S., Joseph K. Salama, Kerstin Stenson, et al.. (2010). Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer. Radiotherapy and Oncology. 97(2). 318–321. 7 indexed citations
9.
Mouw, Kent W., Daniel J. Haraf, Kerstin Stenson, et al.. (2010). Factors Associated With Long-term Speech and Swallowing Outcomes After Chemoradiotherapy for Locoregionally Advanced Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 136(12). 1226–1226. 17 indexed citations
10.
Nichols, Michael A., Loren K. Mell, Michael D. Hasselle, et al.. (2010). Outcomes in Black Patients With Early Breast Cancer Treated With Breast Conservation Therapy. International Journal of Radiation Oncology*Biology*Physics. 79(2). 392–399. 3 indexed citations
11.
Mell, Loren K., James J. Dignam, Joseph K. Salama, et al.. (2009). Predictors of Competing Mortality in Advanced Head and Neck Cancer. Journal of Clinical Oncology. 28(1). 15–20. 348 indexed citations
12.
Cohen, Ezra E.W., Dezheng Huo, Daniel J. Haraf, et al.. (2009). Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head & Neck. 31(8). 1013–1021. 47 indexed citations
13.
Cohen, Ezra E.W., Daniel J. Haraf, Marcy A. List, et al.. (2006). High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial. Journal of Clinical Oncology. 24(21). 3438–3444. 17 indexed citations
14.
15.
Salama, Joseph K., Everett E. Vokes, Steven J. Chmura, et al.. (2005). Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. International Journal of Radiation Oncology*Biology*Physics. 64(2). 382–391. 198 indexed citations
16.
Haraf, Daniel J., Fred Rosen, Kerstin Stenson, et al.. (2003). Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.. PubMed. 9(16 Pt 1). 5936–43. 63 indexed citations
17.
18.
Rosen, Fred, Daniel J. Haraf, Merrill S. Kies, et al.. (2003). Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.. PubMed. 9(5). 1689–97. 62 indexed citations
19.
Vokes, Everett E., Merrill S. Kies, Daniel J. Haraf, et al.. (2000). Concomitant Chemoradiotherapy as Primary Therapy for Locoregionally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 18(8). 1652–1661. 171 indexed citations
20.
Haraf, Daniel J., Merrill S. Kies, Alfred Rademaker, et al.. (1999). Radiation Therapy With Concomitant Hydroxyurea and Fluorouracil in Stage II and III Head and Neck Cancer. Journal of Clinical Oncology. 17(2). 638–638. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fred Rosen Breakdown of academic impact, for papers by A A Forastiere Breakdown of academic impact, for papers by T. Vuong Breakdown of academic impact, for papers by Roger K.C. Ngan Breakdown of academic impact, for papers by A Rey Breakdown of academic impact, for papers by Lionnel Geoffrois Breakdown of academic impact, for papers by John Showel Breakdown of academic impact, for papers by L. Geoffrois Breakdown of academic impact, for papers by Kinji Nishiyama Breakdown of academic impact, for papers by R. Semrau
Rankless by CCL
2026